The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 09, 2018

Filed:

Mar. 05, 2015
Applicant:

Nestec S.a., Vevey, CH;

Inventors:

Norbert Sprenger, Savigny, CH;

Francois Morgan, Rennes, FR;

Rafael Berrocal, Sant-Legier, CH;

Marcel Braun, Konolfingen, CH;

Christine Cherbut, Pully, CH;

Peter Duncan, Epalinges, CH;

Assignee:

Nestec S.A., Vevey, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A23L 1/30 (2006.01); A61K 35/74 (2015.01); A61K 35/747 (2015.01); A23C 9/142 (2006.01); A61K 35/745 (2015.01); A61K 47/26 (2006.01); A23L 33/00 (2016.01); A23L 33/10 (2016.01); A23L 33/135 (2016.01); A23L 33/26 (2016.01);
U.S. Cl.
CPC ...
A61K 35/747 (2013.01); A23C 9/1425 (2013.01); A23L 33/10 (2016.08); A23L 33/135 (2016.08); A23L 33/26 (2016.08); A23L 33/40 (2016.08); A61K 35/745 (2013.01); A61K 47/26 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/63 (2013.01); A23Y 2220/71 (2013.01); A23Y 2220/73 (2013.01); A23Y 2300/29 (2013.01); A23Y 2300/49 (2013.01); A23Y 2300/55 (2013.01);
Abstract

This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group consisting of Ga1NAcα1-3Ga1β1-4G1c, Ga1β1-6Ga1Nacα1-3Ga1β1-4G1c and combinations thereof, 20-95 wt % of at least one neutral oligosaccharide selected from the group consisting of Galβ1-6Gal, Galβ1-6Galβ1-4Glc, Galβ1-6Galβ1-6Glc, Galβ1-3Galβ1-3Glc, Galβ1-3Galβ1-4Glc, Galβ1-6Galβ1-6Galβ1-4Glc, Galβ1-6Galβ1-3Galβ1-4Glc, Galβ1-3Galβ1-6Galβ1-4Glc, Galβ1-3Galβ1-3Galβ1-4Glc and combinations thereof and 2-50 wt % of at least one sialylated oligosaccharide selected from the group consisting of NeuAcα2-3Galβ1-4Glc, NeuAcα2-6Ga1β1-4G1c and combinations thereof. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.


Find Patent Forward Citations

Loading…